Food and Drug Administration (FDA) Disclosure:

The statements in this forum have not been evaluated by the Food and Drug Administration and are generated by non-professional writers. Any products described are not intended to diagnose, treat, cure, or prevent any disease.

Website Disclosure:

This forum contains general information about diet, health and nutrition. The information is not advice and is not a substitute for advice from a healthcare professional.

the medicinal uses of cannabis and cannabinoids

Discussion in 'Medical Marijuana Usage and Applications' started by gogo, Apr 2, 2005.

  1. Good news from the Royal Pharmaceutical Society of Great Britain, I have received this e-mail from the lca

    lca wrote:
    Source: Business Wire

    ---
    CHICAGO--(BUSINESS WIRE)The Pharmaceutical Press, the
    publications division of the Royal Pharmaceutical Society of Great Britain,
    with offices in London and Chicago, has published
    The publication is an authoritative review of the development of cannabis-based
    medicines and their applications in a wide range of therapeutic areas. It has
    been edited by Dr Geoffrey W Guy (Executive Chairman, GW Pharmaceuticals), Dr
    Philip J Robson (Senior Research Fellow, Department of Psychiatry, Oxford
    University and Medical Director, GW Pharmaceuticals) and Dr Brian A Whittle
    (Scientific Director, GW Pharmaceuticals).

    The publication focuses on the research, development and clinical trial results
    of the cannabis-based medicinal extract (CBME) Sativex for the relief of
    chronic pain in MS sufferers, currently under review by the MHRA for
    registration. It also covers a broad spectrum of subjects including the history
    of cannabis use, its growth and morphology, the discovery and pharmacology of
    cannabinoid receptors in mammalian tissues, the development and use of
    synthetic cannabinoids, and the legal and forensic aspects of cannabis within
    the international community.

    Further chapters explore the research into the basic science of cannabis and
    cannabinoids and highlight promising applications of CBMEs in the treatment of
    epilepsy, schizophrenia, bladder dysfunction and as broad-spectrum relief
    agents in patients with AIDS or cancer.

    Professor Tony Moffat, the Society's Chief Scientist, said: "This publication
    demonstrates the scientific credentials of cannabis and cannabinoids as
    medicines. It is hoped that the evidence presented will help to change the
    attitude of health professionals towards cannabis-based medicines and enable
    the international legislative change required to allow further collaborative
    research into prescription medicines."

    This is on the Royal Pharmaceutical Society of Great Britain website

    The Medicinal Uses of Cannabis and Cannabinoids
    First edition

    Edited by Geoffrey W Guy - Executive Chairman, GW Pharmaceuticals, UK, Brian A Whittle - Scientific Director and Philip J Robson - Medical Director, GW Pharmaceuticals, UK


    Description:
    Cannabis research has moved beyond its use as an illegal recreational drug. Increasingly, focus is on its potential as a therapeutic substance, particularly in serious chronic illnesses such as multiple sclerosis.


    This new title describes current research findings relating to the medicinal use of cannabis and cannabinoids. Topics covered include the pharmacology, formulation, safety and efficacy of cannabis as a therapeutic agent; growth and breeding of cannabis as a medicine; cannabis for neuropathic pain treatment and for multiple sclerosis; clinical studies and the development of cannabis-based medicine; and forensic and international control of cannabis.


    Written by experts in the UK and USA, this is an essential reference for pharmacists, doctors, pharmacologists and all other healthcare professionals with an interest in cannabis-derived medicines for symptom relief of intractable diseases.


    Contents:
    1. The History of Cannabis As a Medicine: 2. Growth and Morphology of Medicinal Cannabis: 3. The Breeding of Cannabis Cultivars for Pharmaceutical End-uses: 4. The Evolution of Cannabis and Its Coevolution with the Human Cannabinoid Receptor: 5. Receptors and Pharmacodynamics; Natural and Synthtic Cannabinoids and Endocannabinoids: 6. Therapeutic Potential of Cannabis and Cannabinoids in Experimental Models of Multiple Sclerosis: 7. Natural Cannabinoids: Interactions and Effects: 8. Metabolism and Pharmacokinetics of Cannabinoids: 9. Clinical Studies of Cannabis-based Medicine: 10. Cannabis in the Treatment of Neuropathic Pain: 11. Forensic Control of Cannabis: 12. A Review of Cannabis and Driving Skills: 13. International Control of Cannabis: Changing Attitudes: 14. Developing a New Cannabis Based Medicine:

    The Medicinal Uses of Cannabis and Cannabinoids
     

Share This Page